Clinical Trial Update: An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating palovarotene for preosseous flare-ups in Fibrodysplasia Ossificans Progressiva has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrodysplasia Ossificans Progressiva

Drugs mentioned

• Palovarotene (palovarotene)

Snippet

Sponsor: Clementia Pharmaceuticals Inc. | Conditions: Fibrodysplasia Ossificans Progressiva | Phase 2 | Status: COMPLETED | Results posted: 2020-06-24